Bide Pharmatech Co. Ltd. A (688073.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100005NV3
Price
67.56 CNY
Market cap
6.14 bn CNY
P/E (2025)
40.46
P/S (2025)
4.64
Dividend yield
1.72 %
Net margin
11.46 %
Return on equity (ROE)
7.42 %
Return on assets (ROA)
6.03 %
Bide Pharmatech Co. Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.10 bn CNY | 1.32 bn CNY |
| Gross profit | 455.49 m CNY | 589.57 m CNY |
| Operating income | 158.63 m CNY | 241.65 m CNY |
| EBIT | 151.33 m CNY | 201.23 m CNY |
| Net income | 117.43 m CNY | 151.74 m CNY |
| Diluted EPS – continuing operations | 1.29 CNY | 1.67 CNY |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Bide Pharmatech Co. Ltd. A
Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. Bide Pharmatech Co., Ltd. was founded in 2007 and is based in Shanghai, China.
More stocks
- Jiangsu Tongxingbao Intelligent Transportation Technology Co. Ltd. A (301339.SZ)
- Akasha Wira International Tbk (ADES.JK)
- IP Group PLC (IPO.L)
- Huludao Zinc Industry Co Ltd (000751.SZ)
- Safilo Group SpA (SFL.MI)
- Montepino Logistica SOCIMI S.A. (MLMTP.PA)
- CFM Indosuez Wealth SA (MLCFM.PA)
- WAG Payment Solutions PLC (EWG.L)
- Gryphon Capital Income Trust (GCI.AX)
- Carlsberg Brewery Malaysia Bhd (2836.KL)
- Ningbo Kbe Electrical Technology Co (300863.SZ)
- REPUBLIC AIRWAYS HOLDINGS INC. (RJET)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.